Tackling the Serious Global Challenges in Infectious Disease

Appili was created to deliver innovative drug development programs for unmet patient needs across a broad spectrum of infectious diseases

Advancing infectious disease drug development programs to provide solutions to patients, doctors, and society.

Leadership team skilled in advancing programs with upside potential

Active partnering and in-licensing efforts to expand clinical programs and accelerate commercialization

Appili Therapeutics: Innovation Across a Broad Spectrum of Anti-Infectives

LATEST NEWS & EVENTS

Appili Therapeutics Reports Financial and Operational Results for Third Quarter Fiscal Year 2020
02/27/2020
Appili Therapeutics Announces Closing of Public Offering of $10,250,000
02/20/2020
Appili Therapeutics Announces Upsizing of Previously Announced Equity Offering
02/14/2020